Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs Standard-dose Omeprazole for H. pylori Eradication
NCT02922699Phase 4Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of omeprazole in Helicobacter pylori infection (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: H Pylori eradicaion rates at 6 weeks. Started Jan 2013; status: completed.
02
Drugs
omeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02922699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922699.